AstraZeneca (AZN) to Buy Full Stake in Rare Disease Drugmaker Posted byZacks Equity Research September 30, 2021 Leave a comment on AstraZeneca (AZN) to Buy Full Stake in Rare Disease Drugmaker AstraZeneca (AZN) looks to buy full stake in Caelum Biosciences to sharpen its focus on rare-disease drugs.